Peri-implantitis Market Size & Growth Forecast 2027–2036, By Segments (Method Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Peri-implantitis Market size stood at USD 1.2 billion in 2026 and is predicted to grow at a 8.65% CAGR from 2027 to 2036, exceeding USD 2.75 billion by 2036. The industry revenue for 2027 is estimated at USD 1.29 billion.
Get more details on this report
Request Free Sample ReportPeri-implantitis Market Intelligence Snapshot
Regional Market Dynamics
- Europe leads due to its mature dental care infrastructure, broad access to implant-related diagnosis and treatment, and established clinical pathways that sustain consistent procedural volumes.
- Asia Pacific is expected to grow at a 10.4% CAGR, driven by increasing dental implant adoption, improving access to dental services, and rising demand for implant-related follow-up care.
Segment Momentum
- Surgical methods held a 62.06% share in 2026 because they enable direct access to infected implant sites, deeper decontamination, and corrective treatment for advanced peri-implantitis cases.
- Non-surgical methods are growing fastest as clinicians increasingly favor earlier, less invasive interventions that help control inflammation, reduce procedural burden, and support maintenance-focused care before surgery becomes necessary.
Market Expansion Drivers
- Expanding aging population driving higher dental implant procedures and peri-implantitis treatment demand.
- Laser-assisted therapies and antimicrobial implant technologies improving peri-implantitis management outcomes.
- Rising preventive dental care adoption supporting early peri-implant disease diagnosis and intervention.
Leading Market Participants
- Leading players in the peri-implantitis market include Institut Straumann AG (Switzerland), Dentsply Sirona Inc. (United States), Zimmer Biomet Holdings, Inc. (United States), Geistlich Pharma AG (Switzerland), Cadila Pharmaceuticals Limited (India), Basic Pharma Life Science Pvt. Ltd. (India), Healthy Life Pharma Private Limited (India).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.2 billion
- 2027 Estimated Market Size: USD 1.29 billion.
- Projected Market Size: USD 2.75 billion by 2036
- Growth Forecast: 8.65% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: Europe
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Surgical (Method Type)
- Emerging Opportunity Segment: Non-surgical (Method Type)
Market Growth Drivers and Industry Trends
Expanding aging population driving higher dental implant procedures and peri-implantitis treatment demand
An expanding aging population is contributing to peri-implantitis market growth as older adults increasingly require dental restoration solutions to address tooth loss and maintain oral function. Dental implants are widely used in restorative dentistry, but the presence of implants can be associated with inflammatory conditions affecting the surrounding tissues when appropriate maintenance and treatment are not provided. As the number of patients receiving implant-supported restorations increases, the clinical need for diagnosing and managing peri-implant inflammatory conditions also becomes more significant. Age-related changes in oral health, increased susceptibility to periodontal complications, and the need for long-term implant maintenance can further increase demand for specialized peri-implantitis management.
Laser-assisted therapies and antimicrobial implant technologies improving peri-implantitis management outcomes
Technological progress in laser-assisted treatment and antimicrobial implant technologies is supporting peri-implantitis market growth by giving dental professionals more targeted approaches for managing inflammation and bacterial contamination around implants. Laser-based procedures can assist with the removal of diseased tissue and microbial deposits while supporting treatment of affected implant sites, whereas antimicrobial surface technologies are designed to limit bacterial adhesion and improve the biological environment around implants. These approaches can complement conventional periodontal therapies and provide clinicians with additional options when managing persistent or complex peri-implant conditions. Continued development of treatment technologies is also increasing the range of approaches available for preserving implant function and supporting surrounding tissue health.
Rising preventive dental care adoption supporting early peri-implant disease diagnosis and intervention
Greater adoption of preventive dental care is strengthening peri-implantitis market demand by encouraging patients and dental professionals to identify implant-related complications at earlier stages. Routine examinations, professional cleanings, oral hygiene monitoring, and regular assessment of implant-supported restorations can help detect inflammatory changes before they progress to more advanced tissue and bone damage. Increasing patient awareness of the importance of maintaining dental implants over the long term is also encouraging adherence to follow-up appointments and personalized oral hygiene practices. Earlier clinical intervention can provide dentists with greater opportunity to manage infection and inflammation through appropriate therapeutic and maintenance procedures.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Expanding aging population driving higher dental implant procedures and peri-implantitis treatment demand | 2.00% | High | North America, Europe, Asia Pacific | High | Near Term |
| Laser-assisted therapies and antimicrobial implant technologies improving peri-implantitis management outcomes | 1.80% | High | North America, Europe | Medium | Mid Term |
| Rising preventive dental care adoption supporting early peri-implant disease diagnosis and intervention | 1.40% | Moderate | Asia Pacific, Latin America | Emerging | Mid Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
Europe (Largest Region)
Europe accounted for the largest share of the peri-implantitis market in 2026, reflecting its advanced dental healthcare infrastructure, strong adoption of implant-based treatments, and established periodontal care capabilities. Growing awareness of complications associated with dental implants is encouraging earlier diagnosis and management of peri-implant conditions. The region's aging population, high access to specialized dental services, and emphasis on preventive oral healthcare further support demand for diagnostic and therapeutic solutions. Established clinical practices and continued adoption of advanced dental technologies are also reinforcing the region's strong market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is experiencing the fastest growth as dental care infrastructure improves and access to implant-based treatments expands across the region. Rising healthcare expenditure, increasing awareness of oral health, and growing demand for restorative and cosmetic dental procedures are creating a broader patient base requiring long-term implant maintenance. Improvements in dental clinics and specialist services are facilitating earlier recognition and treatment of peri-implant complications. In addition, expanding medical tourism and greater adoption of modern dental technologies are supporting the development of specialized periodontal care capabilities.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
Germany 🇩🇪
Evidence-Based Treatment ProtocolsGermany focuses on clinically validated peri-implantitis management supported by structured implant maintenance and periodontal care. Dental clinics in Germany prioritize minimally invasive treatment approaches and preventive monitoring to improve implant longevity.
France 🇫🇷
Specialized Periodontal CareFrance strengthens peri-implantitis management through collaboration between implant specialists and periodontal practitioners. Dental clinics in France focus on preserving implant function using individualized treatment protocols and comprehensive maintenance programs.
Italy 🇮🇹
Implant Maintenance FocusItaly prioritizes peri-implantitis management through preventive care, regular monitoring, and advanced surgical techniques when necessary. Dental professionals in Italy emphasize preserving implant stability while improving patient outcomes through tailored treatment approaches.
Japan 🇯🇵
Preventive Implant MonitoringJapan emphasizes routine implant maintenance and early intervention strategies to reduce peri-implant complications. Dental practitioners in Japan increasingly incorporate precision diagnostics and patient follow-up protocols to support successful long-term implant performance.
South Korea 🇰🇷
Digital Dental IntegrationSouth Korea combines digital dentistry with peri-implantitis diagnosis and treatment planning to improve clinical precision. Dental providers in South Korea continue investing in imaging technologies and advanced implant care solutions that support effective disease management.
United States 🇺🇸
Advanced Implant CareThe U.S. peri-implantitis market is supported by growing emphasis on preserving long-term dental implant outcomes through early diagnosis and specialized treatment. Dental professionals in the U.S. increasingly adopt regenerative procedures and advanced diagnostic tools to improve patient care.
Peri-implantitis Market Share (%), by Method Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportMethod Type Segment Analysis: Surgical (Largest Segment) vs Non-surgical (Fastest-Growing Segment)
The surgical segment represented the largest share of the peri-implantitis market at 62.06% in 2026, reflecting the need for direct intervention in advanced or persistent peri-implant disease where non-surgical approaches may be insufficient. Surgical procedures can provide access to affected implant surfaces, enable removal of diseased tissue, and support treatment of complex defects. Increasing clinical attention to implant maintenance and the management of complications is reinforcing the role of surgical approaches in comprehensive peri-implantitis care.
Non-surgical treatment is gaining momentum as clinicians increasingly emphasize early intervention, disease monitoring, and conservative management of peri-implant inflammation. Mechanical debridement, antimicrobial approaches, and improved maintenance protocols can help control disease before more invasive procedures become necessary. Growing awareness of preventive implant care and the importance of regular professional maintenance is supporting broader use of non-surgical treatment strategies.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Method Type | Surgical, Non-surgical | Surgical | Non-surgical |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Key companies in the peri-implantitis market:
1. Institut Straumann AG (Switzerland)
2. Dentsply Sirona Inc. (United States)
3. Zimmer Biomet Holdings Inc. (United States)
4. Geistlich Pharma AG (Switzerland)
5. Cadila Pharmaceuticals Limited (India)
6. Basic Pharma Life Science Pvt. Ltd. (India)
7. Healthy Life Pharma Private Limited (India)
The peri-implantitis market is witnessing increased activity surrounding the development of advanced treatment systems and regenerative therapies aimed at improving dental implant outcomes. Research-focused innovation in infection control technologies and minimally invasive procedures is helping expand available treatment options. Consolidation strategies and collaborative clinical development initiatives are also contributing to stronger competitive positioning across the market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Institut Straumann AG (Switzerland) | |||||||
| Dentsply Sirona Inc. (United States) | |||||||
| Zimmer Biomet Holdings Inc. (United States) | |||||||
| Geistlich Pharma AG (Switzerland) | |||||||
| Cadila Pharmaceuticals Limited (India) | |||||||
| Basic Pharma Life Science Pvt. Ltd. (India) | |||||||
| Healthy Life Pharma Private Limited (India). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Swiss Dental Solutions (SDS) | Jan-26 | Swiss Dental Solutions promoted its ceramic implant system, which offers both one- and two-piece configurations. By prioritizing material biocompatibility, the system is positioned as a strategic alternative to traditional implant materials, aiming to mitigate the risk of peri-implantitis and improve long-term clinical outcomes for patients undergoing implant-supported restorative procedures. |
| Integral Dental | Oct-24 | Integral Dental launched OraclePI, an early-stage diagnostic test for peri-implant disease. The system leverages patient-specific data to facilitate early detection and the formulation of personalized treatment plans. This development enhances the company’s diagnostic capabilities and addresses a critical need for proactive clinical management of peri-implant conditions. |
| Young Specialties | Mar-24 | Young Specialties introduced PerioDT, a specialized debridement solution utilizing proprietary Dessication Technology. The product launch expands the company’s periodontal treatment portfolio, providing clinicians with a targeted chemical debridement material designed to support standard procedures in the clinical management and care of peri-implantitis. |
| Institut Straumann AG | May-23 | Institut Straumann AG completed the acquisition of GalvoSurge, a medical device manufacturer specializing in implant maintenance. This integration expands Straumann's clinical portfolio by incorporating a proprietary, CE-marked technology for peri-implantitis treatment, strengthening its competitive position in the global market for implant care and disease management solutions. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Peri-implantitis Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Disease Severity | Early Peri-implantitis, Moderate Peri-implantitis, Advanced Peri-implantitis |
| Implant Duration | Less Than 5 Years, 5–10 Years, More Than 10 Years |
| Treatment Setting | Dental Clinics, Dental Hospitals, Academic & Specialty Centers |
Peri-implantitis Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Dental Implant Complication Management Landscape |
|
| Treatment Adoption Barrier Analysis |
|
| Patient Journey and Treatment Gap Analysis |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
How big is the peri-implantitis market?
How is the peri-implantitis industry projected to perform over the next decade?
How is the growing aging population influencing demand in the peri-implantitis market?
How are advancements in diagnostic and treatment technologies shaping peri-implantitis management approaches?
Why do surgical methods dominate the peri-implantitis market?
Why are non-surgical methods the fastest-growing segment in the peri-implantitis market?
What makes Europe the leading regional market for peri-implantitis treatment?
Why is Asia Pacific the fastest-growing peri-implantitis market?
Who are the major participants shaping the peri-implantitis landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook